Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H15NO2 |
| Molecular Weight | 193.2423 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)COC(=O)C1=CC=C(N)C=C1
InChI
InChIKey=PUYOAVGNCWPANW-UHFFFAOYSA-N
InChI=1S/C11H15NO2/c1-8(2)7-14-11(13)9-3-5-10(12)6-4-9/h3-6,8H,7,12H2,1-2H3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/15955643Curator's Comment: description was created based on several sources, including
http://www.drugfuture.com/chemdata/Isobutyl-p-Aminobenzoate.html
http://isms.illinois.edu/2016/schedule/abstract_files/1662.pdf
Sources: http://www.ncbi.nlm.nih.gov/pubmed/15955643
Curator's Comment: description was created based on several sources, including
http://www.drugfuture.com/chemdata/Isobutyl-p-Aminobenzoate.html
http://isms.illinois.edu/2016/schedule/abstract_files/1662.pdf
Isobutamben is a local anaesthetic agent, used for surgery and dental procedures. The drug was marketed under the name Cycloform, however its current marketing status is unknown and supposed to be "withdrawn".
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
||
|
CFR |
21 CFR 310.531
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
202-308-2
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
94-14-4
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL1985617
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
DTXSID9023170
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
m6448
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000082807
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
4408
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
SUB08312MIG
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
C75962
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
7176
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
9566855ULN
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY | |||
|
23517
Created by
admin on Mon Mar 31 17:53:27 GMT 2025 , Edited by admin on Mon Mar 31 17:53:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY